Here, we report on the identification of a highly polymorphic tetranucleotide repeat (named DXpS) mapping to within a CpG island on the Xp. This island is 191 bp upstream from the start of the repeat element, and contains sites for the HhaI, HpaII and BstUI methyl-sensitive restriction enzymes ( Figure 1 ). We developed the DXpS and the HUMARA markers into a biplex methylation-based quantitative fluorescent PCR assay. For DXpS we observed twelve alleles with negligible stuttering (Figure 2 ). DXpS exhibited a heterozygosity rate of 87% (n = 60), matching that of HUMARA. The combined informativeness of the biplex assay was 98%. Random and nonrandom X-inactivation patterns inferred with DXpS in phenotypically normal females and haemophiliac females carrying a defective F8 gene were highly concordant (r 2 = 0.96) with HUMARA patterns (Figures 3, 4 and 5). 
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Identification of a highly polymorphic tetranucleotide repeat locus (DXpS) at Xp and development of a DXpS/HUMARA biplex methylation-based PCR assay that enhances detection of X-chromosome inactivation RESULTS
DXpS represents a notable advancement in detecting X-chromosome inactivation due to the observed high rate of heterozygosity, negligible occurrence of stutters, concordance with HUMARA, and the apparent neutrality of allelic variants.
CONCLUSION
In silico mining of microsatellites
Distance of CpG island <300bp
Concordance with the HUMARA assay Presence of methylation sensitive restriction enzyme site
The aim was to verify the presence of microsatellites tetra-and pentanucleotides near differentially methylated CpG islands in promoter regions of the human X chromosome, and develop a methylationbased PCR assay that enhances detection of X-chromosome inactivation.
The identification of microsatellites was performed in silico with bioinformatics tools, and criteria developed by the group regarding the in silico prediction of informativeness. We analyzed promoter regions of genes that do not escape the inactivation of chromosome X, 2 containing CpG islands which had been validated in vitro 3,4 .
The methylation-based PCR assay in exon 1 of the human androgen receptor AR gene (HUMARA) is the gold standard indirect method for determination of activation status of human X chromosomes. The test is based on differential methylation between the active X chromosome (unmethylated) and inactive (methylated) of a CpG island in Xq12, close to a highly polymorphic (CAG) n microsatellite. HUMARA assay provides heterozygosity rates ~85% worldwide. This means that in a proportion of females the HUMARA assay is uninformative. Allele designation and quantification from trinucleotide repeats demand normalizing for minor (stutter) products differing from the original template by multiples of the repeat unit. Moreover, the HUMARA genotype is not neutral, being linked to Kennedy´s disease and has been implicated in breast cancer risk. 1 Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet. 6, e1001134.
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